Nelson, Van Denburg & Campbell Wealth Management Group, LLC Atai Life Sciences N.V. Transaction History
Nelson, Van Denburg & Campbell Wealth Management Group, LLC
- $2.63 Billion
- Q4 2024
A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 57 shares of ATAI stock, worth $83. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57Holding current value
$83% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
88Shares Held
12.4MCall Options Held
77.8KPut Options Held
50.3K-
Morgan Stanley New York, NY3.04MShares$4.44 Million0.0% of portfolio
-
Walleye Capital LLC Plymouth, MN2.26MShares$3.31 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.91 Million0.0% of portfolio
-
Brown University719KShares$1.05 Million0.36% of portfolio
-
Round Table Services, LLC704KShares$1.03 Million0.46% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $242M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...